首页>
外国专利>
2,6-Dimethyl-3,5-dicarbonyl (or dicyano)-1,4-dihydropyridine prepns - used in treatment of hepatic diseases caused by peroxidative damage of biological membranes
2,6-Dimethyl-3,5-dicarbonyl (or dicyano)-1,4-dihydropyridine prepns - used in treatment of hepatic diseases caused by peroxidative damage of biological membranes
Preparations containing as active component a 2, 6-dimethyl-3, 5-dicarbonyl (or 3, 5-dicyano)-1, 4-dihydro pyridine of general formula (I): (where R - alkyl, opt. substd. carbalkoxy, substd. carbamoyl or cyano; R1 = H, alkyl, aryl or beta-pyridyl) are new. Named cpd. (I) is 2,6-dimethyl-3, 5-dicarbethoxy-1, 4-dihydropyridine(ethydine). Ethydine (I) inhibits peroxidative processes in biological membranes in organs esp. the liver and may be used in the treatment of those liver diseases such as necrotic liver alterations, fatty hepatosis, virus hepatitis etc. (I) has anti-oxidative activity and may also be used as a stabilising agent for biological membranes or other tissues in the organism. (I) has high specific activity and no side-effectS. It is stable in closed containers.
展开▼
机译:含有通式(I)的2,6-二甲基-3,5-二羰基(或3,5-二氰基)-1,4-二氢吡啶作为活性成分的制剂:(其中R-烷基,优选为烷氧基,例如氨基甲酰基或氰基; R 1 = H,烷基,芳基或β-吡啶基)是新的。命名为cpd。 (I)是2,6-二甲基-3、5-二乙氧基-1、4-二氢吡啶(乙啶)。乙二胺(I)抑制器官尤其是生物膜中的过氧化过程。 (I)具有抗氧化活性,还可以用作生物膜或其他组织的稳定剂,可用于治疗肝脏疾病,如坏死性肝改变,脂肪性肝病,病毒性肝炎等。有机体。 (I)具有高的比活度并且没有副作用。在密闭容器中稳定。
展开▼